Improving the quality of life of patients with prostate carcinoma: A randomized trial testing the efficacy of a nurse-driven intervention

R. Brian Giesler, Barbara Given, Charles W. Given, Susan Rawl, Patrick Monahan, Debra Burns, Faouzi Azzouz, Kristina M. Reuille, Sally Weinrich, Michael Koch, Victoria Champion

Research output: Contribution to journalArticle

99 Citations (Scopus)

Abstract

BACKGROUND. Treatments for clinically localized prostate carcinoma are accompanied by sexual, urinary, and bowel dysfunction and other sequelae that can result in significant distress and reduced well being. Methods capable of improving quality of life are needed that can be integrated into clinical practice. To address this need, a nurse-driven, cancer care intervention was developed and tested. METHODS. Within 6 weeks after completing treatment, 99 patients, along with their partners, were enrolled into a prospective, controlled trial and were randomized to receive the cancer care intervention or to receive standard care. Participants in the intervention arm met once each month for 6 months with an oncology nurse intervenor, who helped patients identify their quality-of-life needs using an interactive computer program. The intervener then provided education and support tailored to participants' needs. Primary outcome variables included 1) disease-specific quality of life, including sexual, urinary, and bowel outcomes and cancer worry; 2) depression; 3) dyadic adjustment; and 4) general quality of life. Outcomes data were collected prior to randomization and again at 4 months, 7 months, and 12 months posttreatment. RESULTS. Patients in the intervention arm experienced long-term improvements in quality-of-life outcomes related to sexual functioning and cancer worry compared with patients who received standard care. Baseline depression moderated the impact of the intervention on several other quality-of-life outcomes. CONCLUSIONS. The findings of the current study indicated that a computer-assisted, nurse-driven intervention was capable of providing durable improvements in the quality of life of men who underwent treatment for clinically localized prostate carcinoma.

Original languageEnglish
Pages (from-to)752-762
Number of pages11
JournalCancer
Volume104
Issue number4
DOIs
StatePublished - Aug 15 2005

Fingerprint

Prostate
Nurses
Quality of Life
Carcinoma
Neoplasms
Random Allocation
Therapeutics
Software
Randomized Controlled Trials
Education

Keywords

  • Prostate carcinoma
  • Psychosocial oncology
  • Quality of life
  • Randomized controlled trial

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Improving the quality of life of patients with prostate carcinoma : A randomized trial testing the efficacy of a nurse-driven intervention. / Giesler, R. Brian; Given, Barbara; Given, Charles W.; Rawl, Susan; Monahan, Patrick; Burns, Debra; Azzouz, Faouzi; Reuille, Kristina M.; Weinrich, Sally; Koch, Michael; Champion, Victoria.

In: Cancer, Vol. 104, No. 4, 15.08.2005, p. 752-762.

Research output: Contribution to journalArticle

Giesler, R. Brian ; Given, Barbara ; Given, Charles W. ; Rawl, Susan ; Monahan, Patrick ; Burns, Debra ; Azzouz, Faouzi ; Reuille, Kristina M. ; Weinrich, Sally ; Koch, Michael ; Champion, Victoria. / Improving the quality of life of patients with prostate carcinoma : A randomized trial testing the efficacy of a nurse-driven intervention. In: Cancer. 2005 ; Vol. 104, No. 4. pp. 752-762.
@article{e09b7a3fff714a4f9eb41388bf9d0315,
title = "Improving the quality of life of patients with prostate carcinoma: A randomized trial testing the efficacy of a nurse-driven intervention",
abstract = "BACKGROUND. Treatments for clinically localized prostate carcinoma are accompanied by sexual, urinary, and bowel dysfunction and other sequelae that can result in significant distress and reduced well being. Methods capable of improving quality of life are needed that can be integrated into clinical practice. To address this need, a nurse-driven, cancer care intervention was developed and tested. METHODS. Within 6 weeks after completing treatment, 99 patients, along with their partners, were enrolled into a prospective, controlled trial and were randomized to receive the cancer care intervention or to receive standard care. Participants in the intervention arm met once each month for 6 months with an oncology nurse intervenor, who helped patients identify their quality-of-life needs using an interactive computer program. The intervener then provided education and support tailored to participants' needs. Primary outcome variables included 1) disease-specific quality of life, including sexual, urinary, and bowel outcomes and cancer worry; 2) depression; 3) dyadic adjustment; and 4) general quality of life. Outcomes data were collected prior to randomization and again at 4 months, 7 months, and 12 months posttreatment. RESULTS. Patients in the intervention arm experienced long-term improvements in quality-of-life outcomes related to sexual functioning and cancer worry compared with patients who received standard care. Baseline depression moderated the impact of the intervention on several other quality-of-life outcomes. CONCLUSIONS. The findings of the current study indicated that a computer-assisted, nurse-driven intervention was capable of providing durable improvements in the quality of life of men who underwent treatment for clinically localized prostate carcinoma.",
keywords = "Prostate carcinoma, Psychosocial oncology, Quality of life, Randomized controlled trial",
author = "Giesler, {R. Brian} and Barbara Given and Given, {Charles W.} and Susan Rawl and Patrick Monahan and Debra Burns and Faouzi Azzouz and Reuille, {Kristina M.} and Sally Weinrich and Michael Koch and Victoria Champion",
year = "2005",
month = "8",
day = "15",
doi = "10.1002/cncr.21231",
language = "English",
volume = "104",
pages = "752--762",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Improving the quality of life of patients with prostate carcinoma

T2 - A randomized trial testing the efficacy of a nurse-driven intervention

AU - Giesler, R. Brian

AU - Given, Barbara

AU - Given, Charles W.

AU - Rawl, Susan

AU - Monahan, Patrick

AU - Burns, Debra

AU - Azzouz, Faouzi

AU - Reuille, Kristina M.

AU - Weinrich, Sally

AU - Koch, Michael

AU - Champion, Victoria

PY - 2005/8/15

Y1 - 2005/8/15

N2 - BACKGROUND. Treatments for clinically localized prostate carcinoma are accompanied by sexual, urinary, and bowel dysfunction and other sequelae that can result in significant distress and reduced well being. Methods capable of improving quality of life are needed that can be integrated into clinical practice. To address this need, a nurse-driven, cancer care intervention was developed and tested. METHODS. Within 6 weeks after completing treatment, 99 patients, along with their partners, were enrolled into a prospective, controlled trial and were randomized to receive the cancer care intervention or to receive standard care. Participants in the intervention arm met once each month for 6 months with an oncology nurse intervenor, who helped patients identify their quality-of-life needs using an interactive computer program. The intervener then provided education and support tailored to participants' needs. Primary outcome variables included 1) disease-specific quality of life, including sexual, urinary, and bowel outcomes and cancer worry; 2) depression; 3) dyadic adjustment; and 4) general quality of life. Outcomes data were collected prior to randomization and again at 4 months, 7 months, and 12 months posttreatment. RESULTS. Patients in the intervention arm experienced long-term improvements in quality-of-life outcomes related to sexual functioning and cancer worry compared with patients who received standard care. Baseline depression moderated the impact of the intervention on several other quality-of-life outcomes. CONCLUSIONS. The findings of the current study indicated that a computer-assisted, nurse-driven intervention was capable of providing durable improvements in the quality of life of men who underwent treatment for clinically localized prostate carcinoma.

AB - BACKGROUND. Treatments for clinically localized prostate carcinoma are accompanied by sexual, urinary, and bowel dysfunction and other sequelae that can result in significant distress and reduced well being. Methods capable of improving quality of life are needed that can be integrated into clinical practice. To address this need, a nurse-driven, cancer care intervention was developed and tested. METHODS. Within 6 weeks after completing treatment, 99 patients, along with their partners, were enrolled into a prospective, controlled trial and were randomized to receive the cancer care intervention or to receive standard care. Participants in the intervention arm met once each month for 6 months with an oncology nurse intervenor, who helped patients identify their quality-of-life needs using an interactive computer program. The intervener then provided education and support tailored to participants' needs. Primary outcome variables included 1) disease-specific quality of life, including sexual, urinary, and bowel outcomes and cancer worry; 2) depression; 3) dyadic adjustment; and 4) general quality of life. Outcomes data were collected prior to randomization and again at 4 months, 7 months, and 12 months posttreatment. RESULTS. Patients in the intervention arm experienced long-term improvements in quality-of-life outcomes related to sexual functioning and cancer worry compared with patients who received standard care. Baseline depression moderated the impact of the intervention on several other quality-of-life outcomes. CONCLUSIONS. The findings of the current study indicated that a computer-assisted, nurse-driven intervention was capable of providing durable improvements in the quality of life of men who underwent treatment for clinically localized prostate carcinoma.

KW - Prostate carcinoma

KW - Psychosocial oncology

KW - Quality of life

KW - Randomized controlled trial

UR - http://www.scopus.com/inward/record.url?scp=23444448401&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23444448401&partnerID=8YFLogxK

U2 - 10.1002/cncr.21231

DO - 10.1002/cncr.21231

M3 - Article

C2 - 15986401

AN - SCOPUS:23444448401

VL - 104

SP - 752

EP - 762

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 4

ER -